0001181431-14-029265.txt : 20140814
0001181431-14-029265.hdr.sgml : 20140814
20140814200008
ACCESSION NUMBER: 0001181431-14-029265
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140813
FILED AS OF DATE: 20140814
DATE AS OF CHANGE: 20140814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDIVATION, INC.
CENTRAL INDEX KEY: 0001011835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133863260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-543-3470
MAIL ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: ORION ACQUISITION CORP II
DATE OF NAME CHANGE: 19960408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seely Lynn
CENTRAL INDEX KEY: 0001327111
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32836
FILM NUMBER: 141044831
MAIL ADDRESS:
STREET 1: 501 2ND STREET
STREET 2: SUITE 211
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
4
1
rrd414618.xml
SEELY -- 8/13/14 EXERCISE AND SALE
X0306
4
2014-08-13
0
0001011835
MEDIVATION, INC.
MDVN
0001327111
Seely Lynn
C/O MEDIVATION, INC.
525 MARKET ST., 36TH FLOOR
SAN FRANCISCO
CA
94105
0
1
0
0
Chief Medical Officer
Common Stock
2014-08-13
4
M
0
12500
9.385
A
71522
D
Common Stock
2014-08-13
4
M
0
7500
6.735
A
79022
D
Common Stock
2014-08-13
4
S
0
11000
83.12
D
68022
D
Common Stock
2014-08-13
4
S
0
5700
84.01
D
62322
D
Common Stock
2014-08-13
4
S
0
3300
84.63
D
59022
D
Stock Option (Right to Buy)
9.385
2014-08-13
4
M
0
12500
0.00
D
2018-10-31
Common Stock
12500
20000
D
Stock Option (Right to Buy)
6.735
2014-08-13
4
M
0
7500
0.00
D
2020-12-15
Common Stock
7500
45000
D
Shares sold pursuant to a 10b5-1 Plan.
The shares were sold at prices ranging from $82.70 to $83.68. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $83.75 to $84.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $84.52 to $84.79. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Fully vested.
The shares subject to the option shall become vested in according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) vested on December 15, 2011, and 1/48th of the shares subject to the option (rounded down to the next whole number of shares) vest on the first day of each month thereafter.
/s/ Jennifer Rhodes, Attorney-in-fact
2014-08-14